Loading...
Loading...
BMO Capital Markets maintains its Perform rating and $18.50 price target on Silver Standard Resources
SSRI as the company provides a resource update for its Pitarrilla project.
BMO Capital Markets says, "Details released on SSRI's development strategy provide investors a clearer understanding of the future sizing and production potential for Pitarilla. The expanded development scenario for Pitarilla is significantly larger than the
underground development outlined in the Q3/09 pre-feasibility study. BMO Research currently models a mineable resource of 77Moz silver based on the sulphide resources and a 4.0ktpd underground operation."
SSRI closed at $16.74 a share on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in